Second-line Urothelial Carcinoma
1 clinical trials · Condition
◉ Watch Second-line Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors (NCT05338580) | TJ Biopharma Co., Ltd. | 2023-12-31 |
Track Second-line Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.